Last update:
Oncology news
Scientists discover lung cancer's 'bodyguard system'—and how to disarm it
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal ...
12 hours ago
0
39
Inflammation gives mutated blood stem cells an edge in cancer development
A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with specific genetic mutations face a heightened risk of developing serious blood cancers.
13 hours ago
0
31
Eye-surgery laser could be adapted for other organs, say scientists
Scientists in Scotland have shown that a type of laser already similar to the one currently used in routine eye surgery could one day help surgeons remove unwanted tissues, such as tumors, with unprecedented accuracy.
13 hours ago
0
0
New therapy combination yields high remission rates in early-stage Hodgkin lymphoma
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of therapies—brentuximab vedotin and nivolumab combined with chemotherapy drugs doxorubicin and dacarbazine—according ...
15 hours ago
0
0
Different types of brain tumors: What they are, how they present and what to expect
Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere).
16 hours ago
0
0
Cancer tumors may protect against Alzheimer's by cleaning out protein clumps
Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about a curious aspect of these two conditions: people who survive cancers are significantly less likely ...
Using lab-grown lung tumors as test subjects for tailored cancer therapies
Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers at the Berlin Institute of Health at Charité (BIH) have developed a method to evaluate multiple ...
Jan 24, 2026
0
47
Muscle loss during cervical cancer treatment linked to sixfold higher death risk
Women with cervical cancer who experience significant muscle loss during treatment die at six times the rate of those who maintain muscle mass, according to an international review of 23 studies involving more than 4,000 ...
Jan 24, 2026
0
0
From diagnosis to treatment and care: Understanding mesothelioma
Mesothelioma is a rare type of cancer, most often caused by exposure to asbestos, according to the U.S. Centers for Disease Control and Prevention (CDC). Mesothelioma develops in the thin tissue surrounding the lungs and ...
Jan 24, 2026
0
0
Regenerating lost lymph nodes with bioengineered tissues
The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes. Although these procedures play a major role in cancer staging and preventing the spread of malignancies, ...
Jan 23, 2026
0
2
A mechanical view on metastasis: Tumor cell viscosity found to guide key steps in cancer spread
Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the original tumor and settle in other parts of the body to form metastases. On their way, they have ...
Jan 23, 2026
0
0
CAR T cells with boosted BACH2 protein can fight cancer more effectively
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness. ...
Jan 23, 2026
0
4
Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy
After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. The molecule took the team on a six-year journey to systematically ...
Jan 23, 2026
0
0
Tiny molecules called tRNA halves may contribute to prostate cancer cell growth
Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new potential therapeutic target in tiny molecules called tRNA halves.
Jan 23, 2026
0
0
Colon cancer now top cancer killer for Americans under 50, study finds
Colon cancer is now the No. 1 cause of cancer deaths in Americans under 50. It claimed that spot seven years earlier than previously projected. Colon cancer deaths among people under 50 have risen roughly 1% each year since ...
Jan 23, 2026
0
1
Targeted radiation therapy can be safely combined with chemotherapy, study finds
A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered alongside high-dose chemotherapy and systemic therapy without requiring patients to pause their cancer ...
Jan 23, 2026
0
0
Can certain foods prevent stomach cancer?
Can what you eat help you avoid getting stomach cancer? "Most cases of stomach cancer happen sporadically and are purely a matter of bad luck," says Sharon Shiraga, MD, an upper-gastrointestinal surgeon with Keck Medicine ...
Jan 23, 2026
0
1
Discovery illuminates how inflammatory bowel disease promotes colorectal cancer
A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with inflammatory bowel disease (IBD) have a higher risk of colorectal ...
Jan 22, 2026
0
36
Breast cancer study reveals synergistic effect of CDK2 and CDK4/6 combination therapy
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast cancer by simultaneously ...
Jan 22, 2026
0
0
Experimental CAR T therapy targets tumor's immune shield, not cancer cells directly
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the ...
Jan 22, 2026
0
0
AI tool predicts cancer metastasis risk using gene expression signatures
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells remain largely unknown—yet understanding this is crucial for optimizing patient care.
Jan 22, 2026
0
0
Chemotherapy rewires gut bacteria to curb metastasis, research reveals
Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to the gut. It reshapes nutrient availability for intestinal bacteria, forcing the microbiota to adapt.
Jan 22, 2026
0
32
How pancreatic tumors use the MYC protein to evade immune detection
An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers. The scientists identified a potential central mechanism by which cancer cells protect themselves ...
Jan 22, 2026
0
13
Carbon-ion therapy offers nonsurgical option for early breast cancer treatment
For many women with early breast cancer, surgery is effective but life-altering. New five-year data from the National Institutes for Quantum Science and Technology (QST) suggest that a precisely targeted, high-energy particle ...
Jan 22, 2026
0
9
Q&A: Researcher discusses new tool to predict how cancer evolves
Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. In a new study, scientists ...
Jan 22, 2026
0
0
